Pular para o conteúdo Pular para o rodapé
Miglustat: Benefits, Reviews, Info, Side Effects!
Detalhes da receita
Miglustat
Zavesca, N-butyldeoxynojirimycin
Miglustat
Medicamento
Drogas
Somente com receita médica
treatment of type 1 Gaucher disease, treatment of Niemann-Pick disease type C, potential use in other glycosphingolipid storage disorders
Abdominal Pain, Decreased Appetite, Diarrhea, Dizziness, Fatigue, Flatulence, Headache, Menstrual Changes, Muscle Cramps, Nausea, Tremor, Weight Loss
Miglustat is a medication primarily used to treat certain rare genetic disorders, such as Gaucher disease type 1 and Niemann-Pick disease type C. The dosage of miglustat can vary depending on the specific condition being treated, the patient’s age, weight, and overall health, as well as the prescribing doctor’s recommendations. For adult patients with Gaucher disease type 1, the typical dosage is often 100 mg taken orally three times a day. However, for Niemann-Pick disease type C, the dosage might differ, and adjustments may be necessary based on individual patient needs and tolerability. It’s important to follow the prescribing healthcare provider’s instructions and not to adjust the dosage without consulting them. Always refer to the specific guidance provided by a healthcare professional or the medication’s prescribing information for the most accurate and personalized dosage information.
Gaucher disease, niemann-pick disease type c
Miglustat has a generally favorable safety profile.
Nenhuma interação relatada
$1,000 – $1,500
$1,500 for 60 capsules.

Uma Sinopse de

Miglustat

Miglustat is a medication that is primarily used in the treatment of a rare genetic disorder known as Niemann-Pick disease type C (NPC). This condition affects the body’s ability to metabolize cholesterol and other lipids, leading to a buildup of these substances in various organs, particularly the brain. Miglustat works by inhibiting the enzyme responsible for the production of these lipids, thereby reducing their accumulation in the body.

It is important to note that Miglustat is not a cure for NPC, but rather a treatment that can help manage the symptoms of the disease and slow its progression. Patients with NPC may experience a range of symptoms, including cognitive impairment, difficulty with movement, and problems with speech and swallowing. Miglustat has been shown to improve some of these symptoms and may help to stabilize the condition in some patients.

As with any medication, Miglustat can cause side effects, including gastrointestinal issues such as diarrhea, nausea, and abdominal pain. It is important for patients to discuss these potential side effects with their healthcare provider and to report any new or worsening symptoms while taking the medication.

Overall, Miglustat can be a valuable treatment option for patients with NPC, helping to improve their quality of life and potentially slowing the progression of the disease. It is important for patients to work closely with their healthcare team to monitor their response to the medication and make any necessary adjustments to their treatment plan.

Aviso Legal RxDb

As informações fornecidas no RxDB.net são apenas para fins informativos e não pretendem substituir aconselhamento médico profissional, diagnóstico ou tratamento. Sempre consulte um profissional de saúde qualificado, como um médico ou farmacêutico, para quaisquer perguntas ou preocupações sobre sua saúde, medicamentos ou condições médicas. A confiança em qualquer informação fornecida neste site é exclusivamente por sua conta e risco. O RxDB.net não fornece serviços médicos ou farmacêuticos e não é responsável por quaisquer decisões tomadas com base nas informações aqui contidas.

PÁGINA ÚLTIMA ATUALIZAÇÃO

Educação em saúde por meio da agregação

Inscreva-se para receber o boletim informativo do Rx Database!
Bancos de Dados Remotos
Menu
Questões?

Site por Foxco © 2025. Todos os direitos reservados.

0
Adoraria saber sua opinião, comente.x
pt_BRPT